サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1458134

腫瘍アブレーションの世界市場規模、シェア、成長分析：技術別、治療別、用途別 - 産業予測（2024年～2031年）

Global Tumor Ablation Market Size, Share, Growth Analysis, By Technology(Radiofrequency Ablation, Microwave Ablation), By Treatment(Surgical Ablation, Laparoscopic Ablation), By Application(Kidney Cancer, Liver Cancer) - Industry Forecast 2024-2031
出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
腫瘍アブレーションの世界市場規模、シェア、成長分析：技術別、治療別、用途別 - 産業予測（2024年～2031年）
出版日: 2024年03月27日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の腫瘍アブレーションの市場規模は、2022年に14億8,000万米ドルとなり、2023年の16億8,000万米ドルから2031年には46億3,000万米ドルに拡大し、予測期間中（2024年～2031年）にCAGR13.5%で成長すると予測されています。

市場拡大を後押しする2つの主要因は、がん罹患率の上昇と、より安全な治療オプションへの強いニーズです。世界保健機関（WHO）は、2030年までに世界で年間1,000万～1,100万人の新規がん患者が発生すると予測しています。低所得国の新規がん罹患率は80%以上増加し、高所得国の罹患率は半分の40%になると予測されています。今後数年間は、低侵襲・非侵襲治療に対する強いニーズと、すでに利用可能な治療法における発展の有利な可能性が、市場を牽引すると予想されます。

予測期間中、回復時間の短縮、患者の快適性向上、所要時間の短縮などの利点から、外科医や患者の低侵襲手術に対する嗜好が高まっているため、高度腫瘍切除技術に対する需要が増加すると思われます。先進的腫瘍切除術は、従来の治療とは対照的に、一般的に入院を伴わない外来患者処置として実施されるため、全体としてかなり安価です。小さな腫瘍の場合、補助手術が主な治療方針となります。したがって、年間がん発見率はその手術数に間接的な影響を与えます。2020年は、COVID-19期間中に関係当局が実施した検診件数が減少した結果、新たに診断されたがん症例が減少し、市場に大きな影響を与えました。

Global Change Data LabのOur World in Data（OWD）イニシアチブが実施した調査では、がん診断の70％以上を50歳以上が占めていました。この数字はおそらく高齢化とともに増加すると思われます。非侵襲的アブレーション手術に関しては、高齢化社会は主要なターゲットグループです。したがって、予測期間中、高齢者人口の増加により腫瘍アブレーション術の需要が増加すると予想されます。

精度の向上、携帯性、コストの経済性を高める技術が、市場企業を継続的な技術革新と最先端製品の導入に駆り立てています。こうした技術進歩には、冷凍アブレーション、HIFU、画像誘導装置などがあります。病変部のサイズを拡大するために外部から冷却した高周波プローブを使用する冷却高周波変性法の使用は、市場拡大において主要な役割を果たすと予想される今後のアプローチの1つです。仙腸関節の完全な変性を可能にするこの治療により、痛みを和らげることができます。

目次

エグゼクティブサマリー

  • 市場概要
  • 転変

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模の推定
  • 市場の前提条件と制限

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

腫瘍アブレーションの世界市場：技術別

  • 市場概要
  • 高周波アブレーション
  • マイクロ波アブレーション
  • 冷凍アブレーション
  • 不可逆的電気穿孔アブレーション
  • その他のアブレーション技術

腫瘍アブレーションの世界市場：治療別

  • 市場概要
  • 外科的アブレーション
  • 腹腔鏡下アブレーション
  • 経皮的アブレーション

腫瘍アブレーションの世界市場：用途別

  • 市場概要
  • 腎臓がん
  • 肝臓がん
  • 乳がん
  • 肺がん
  • 前立腺がん
  • その他のがん

腫瘍アブレーションの世界市場規模：地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ
  • 中東・アフリカ（MEA）
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング（2021年）
  • 主要市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア（2021年）

主要企業プロファイル

  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson & Johnson（Ethicon, Inc.）
  • AngioDynamics, Inc.
  • EDAP TMS S.A.
  • SonaCare Medical, LLC
  • Merit Medical Systems, Inc.
  • Misonix, Inc.
  • HealthTronics, Inc.
  • Galil Medical Ltd.
  • IceCure Medical Ltd.
  • Monteris Medical, Inc.
  • Perseon Corporation
  • NeuWave Medical（Johnson & Johnson）
  • MedWaves, Inc.
  • Hologic, Inc.
  • Sonacare Inc.（HIFU division）
  • Symple Surgical Inc.
  • BVM Medical Limited
  • Misonix, Inc.
目次
Product Code: SQMIG35A2494

Global Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% during the forecast period (2024-2031).

Two key factors propelling market expansion are the rising incidence of cancer and the strong need for safer treatment options. The World Health Organization (WHO) projects that 10-11 million new cases of cancer will be diagnosed worldwide annually by 2030. It is projected that the rate of new cancer cases in low-income countries would increase by over 80%, while the rate in high-income countries will climb at a rate of half (40%). The market is expected to be driven in the upcoming years by a strong need for minimally invasive and non-invasive therapies, as well as by lucrative potential for development in already available therapeutic choices.

Over the projection period, there will likely be an increase in demand for advanced tumor ablation technologies due to surgeons' and patients' rising preference for minimally invasive procedures because of advantages such quicker recovery times, more patient comfort, and shorter turnaround times. Advanced tumor ablation operations are significantly less expensive overall since they are typically performed as outpatient procedures without a hospital stay, in contrast to traditional therapy. For small tumors, adjuvant surgeries are the main course of treatment. Thus, annual cancer detection rates have an indirect impact on its procedure number. 2020 saw a substantial influence on the market as fewer new cancer cases were diagnosed during COVID-19 as a result of fewer screenings conducted by relevant authorities.

In a survey conducted by Global Change Data Lab's Our World in Data (OWD) initiative, people over 50 accounted for more than 70% of cancer diagnoses. The number is probably going to increase in lockstep with the aging population. When it comes to noninvasive ablation operations, the aging population is the major target group because as people age, their basic systems weaken. Therefore, over the projection period, it is anticipated that the growing aging population will increase demand for tumor ablation procedures.

Technologies that increase precision, portability, and economy of cost are what push market players to continuously innovate and introduce cutting-edge products. These technological advancements include cryoablation, HIFU, and image-guided devices. The use of the cooled radiofrequency degeneration technique with externally chilled radiofrequency probes to expand the size of the lesion is one of the forthcoming approaches that is anticipated to play a major role in market expansion. Pain can be relieved by this treatment, which permits complete degeneration of the sacroiliac joint.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tumor Ablation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tumor Ablation Market Segmental Analysis

Based on end user, region, technology, and application, the global market for tumor ablation is divided into segments. The market is divided into segments according to technology: cryoablation, irreversible electroporation ablation, microwave ablation, radiofrequency ablation, and other ablation methods. The market is divided into three segments based on the type of ablation: percutaneous, laparoscopic, and surgical. The market is divided into categories for kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers based on the application. The global market for tumor ablation is divided into five regions: North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Tumor Ablation Market

The market for tumor ablation is significantly influenced by the increased incidence of cancer worldwide, especially in relation to lung, liver, kidney, and breast malignancies. For patients who may not be good candidates for surgery, tumor ablation procedures provide minimally invasive alternatives to surgery for the treatment of localized tumors.

Restraints in the Global Tumor Ablation Market

Procedures for tumor ablation can be costly, particularly when cutting-edge technologies and imaging guidance are used. Tumor ablation treatments may not be as widely available in developing countries due to the high cost of specialist healthcare personnel, equipment, and consumables.

Market Trends of the Global Tumor Ablation Market

Technological Developments: The market for tumor ablation is seeing a steady stream of technological developments that are resulting in the creation of more sophisticated and accurate ablation methods. These developments include the utilization of robotic systems for increased accuracy, the creation of new energy sources for ablation, and the integration of imaging modalities for real-time guidance. Tumor ablation operations are now safer and more effective because to these technological improvements.

Growing Adoption of Minimally Invasive Procedures: Compared to standard surgical techniques, minimally invasive tumor ablation procedures are becoming more and more common. The use of minimally invasive procedures is being fueled by its benefits, which include fewer incisions, shorter hospital stays, quicker healing times, and a decreased risk of complications. As a less intrusive therapeutic alternative, minimally invasive tumor ablation techniques are becoming more and more popular among patients and healthcare professionals.

Growth in Cancer Prevalence: The market for tumor ablation is significantly influenced by the rising prevalence of cancer in the world. The increasing number of cancer cases, including those of the liver, lung, kidney, and prostate, is driving up need for efficient treatment solutions. When treating localized tumors, tumor ablation techniques present a less invasive alternatives to surgery, making them a feasible therapeutic option for patients who might not be good candidates for surgery.

Growing Interest in Precision Medicine: In oncology, precision medicine-which entails customizing treatment based on unique patient characteristics-is becoming more and more popular. Because tumor ablation techniques can target particular tumor areas while protecting healthy tissues, they are a good fit with the precision medicine principles. Tumor ablation is a desirable treatment method in the era of precision medicine because it can give targeted therapy with little effect on neighboring tissues.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Tumor Ablation Market by Technology

  • Market Overview
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation Ablation
  • and Other Ablation Technologies

Global Tumor Ablation Market by Treatment

  • Market Overview
  • Surgical Ablation
  • Laparoscopic Ablation
  • and Percutaneous Ablation

Global Tumor Ablation Market by Application

  • Market Overview
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • and Other Cancer

Global Tumor Ablation Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (Ethicon, Inc.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EDAP TMS S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SonaCare Medical, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Misonix, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HealthTronics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Galil Medical Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IceCure Medical Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Monteris Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perseon Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuWave Medical (Johnson & Johnson)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedWaves, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sonacare Inc. (HIFU division)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Symple Surgical Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BVM Medical Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Misonix, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments